Reply to Letter to the Editor: 'Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease'

Anatol J Cardiol. 2023 Jan;27(1):56-58. doi: 10.14744/AnatolJCardiol.2022.2335.

Authors

Tuncay Güzel¹, Adem Aktan², Raif Kılıç³, Bayram Arslan⁴, Muhammed Demir⁵, Mehmet Özbek⁵, Faruk Ertaş⁵

Affiliations

¹ Department of Cardiology, Health Science University, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Türkiye.
² Department of Cardiology, Mardin Training and Research Hospital, Mardin, Türkiye.
³ Department of Cardiology, Diyarlife Hospital, Diyarbakır, Türkiye.
⁴ Department of Cardiology, Ergani State Hospital, Diyarbakır, Türkiye.
⁵ Department of Cardiology, Faculty of Medicine, Dicle University, Diyarbakır, Türkiye.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants / therapeutic use
Atrial Fibrillation* / drug therapy
Humans
Kidney Diseases*

Substances

Anticoagulants